Sanofi
Why Robinhood?
You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!About SNY
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories.
SNY Key Statistics
SNY News
Regeneron Pharmaceuticals (REGN), Sanofi (SNYNF) announced an update on their ongoing clinical study. Sanofi and Regeneron are running a proof-of-concept Phase...
Technology Sanofi Tumbles After Board Shockingly Ousts CEO Paul Hudson Licensing Sanofi (SNY) stock skidded Thursday after the pharma giant's board ousted Paul...
An announcement from Sanofi ( (SNY) ) is now available. Sanofi announced on February 12, 2026, that its Board of Directors decided on February 11 not to renew...
Analyst ratings
67%
of 6 ratingsMore SNY News
BofA downgraded Sanofi (SNY) to Neutral from Buy with a price target of EUR 92, down from EUR 102. Sanofi has announced Paul Hudson is leaving and to be succeed...
Sanofi SA (NASDAQ:SNY) on Wednesday decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson's last day as Chief Executive Officer wil...
Sanofi’s (SNY) Board of Directors met on February 11, 2026, and decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson’s last day as...
06:02 EST Sanofi (SNY) says Belen Garijo to succeed Paul Hudson as CEO Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...
(RTTNews) - Sanofi (SAN.PA, SNY), a French pharmaceutical and healthcare company, on Thursday announced that the Board of Directors had decided not to renew the...
Belen Garijo has been CEO of Merck KGaA since 2021. heiko becker/Reuters Sanofi SAN 0.44 %increase; green up pointing triangle said Belen Garijo would succeed...
Sanofi’s (SNY) board has decided not to renew the director mandate of Paul Hudson. Hudson joined Sanofi as CEO in September 2019. Previously, he served as CEO...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.